TEVAR for thoracic mycotic aneurysm: Case report.

Abstract

INTRODUCTION:

Mycobacterium tuberculosis is a cause of mycotic aortic pseudoaneurysms, wich are a rare case with high mortality rates. Three types of dissemination hematogenous by contiguity and direct to the aortic wall are possibles.

PRESENTATION OF CASE:

We report a rare case of tuberculous thoracic aortic pseudo aneurysm, successfully treated endovascularly associated to antituberculosis drugs.

DISCUSSION:

Classically TB pseudoaneurisms have been treated with open surgical therapy.however, they are associated to high morbidity and mortaity with increased lenghts of hospital stay. Due to advancements of endovascular technology, it be cames a good and successful alternative as a treatment, with a background of medical treatment.

CONCLUSION:

Thoracic endovascular aneurysm repair (TEVAR) associated to anti-tuberculosis medication have revolutionized the management and improved the prognosis of this pathology.

• Authors: Ayoub Bounssir, Asmae Jedar, Amine Azghari, Hanae Bouhdadi, Tarik Bakkali, Brahim Lekehal
• Journal: International journal of surgery case reports (Int J Surg Case Rep) Vol. 81 Pg. 105753 (Apr 2021) ISSN: 2210-2612 [Print] Netherlands
• PMID: 33770636 (Publication Type: Case Reports)
• Copyright: Copyright © 2021 The Authors. Published by Elsevier Ltd.. All rights reserved.